The molecular profile of luminal B breast cancer
Chad J CreightonDepartment of Medicine and Dan L Duncan Cancer Center Division of Biostatistics. Baylor College of Medicine, Houston, TX, USAAbstract: Molecular profiling studies have found that estrogen receptor-positive (ER+) human breast cancers are comprised of at least two distinct diseases wit...
Guardado en:
Autor principal: | Creighton CJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bd5bf0ea2a234ec5ad9c19ddc12dd19d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer
por: Chenxuan Yang, et al.
Publicado: (2021) -
The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2–) subtype breast cancer by quantum-dot-based molecular imaging
por: Zhu YY, et al.
Publicado: (2018) -
Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer
por: Sun JZ, et al.
Publicado: (2014) -
Negative progesterone receptor status correlates with increased risk of breast cancer recurrence in luminal B HER2-positive and -negative subtypes
por: Toshiaki Utsumi, et al.
Publicado: (2021) -
Molecular photoacoustic imaging of breast cancer using an actively targeted conjugated polymer
por: Balasundaram G, et al.
Publicado: (2015)